What is Princeton Separations?
Princeton Separations operates as a specialized provider of high-performance tools for separation sciences, boasting over four decades of technical expertise. The company's product portfolio, which includes the well-regarded Centri-Sep and Centri-Spin lines, alongside the innovative Electro-Sep series, serves as a critical infrastructure for molecular biology and analytical chemistry workflows. By focusing on precision and reliability, the firm addresses the complex needs of researchers and laboratory professionals who require consistent results in high-stakes scientific environments. Their active engagement in industry forums, such as ADLM 2024, underscores a commitment to collaborative innovation and the expansion of their footprint in the global biotechnology market.
How much funding has Princeton Separations raised?
Princeton Separations has raised a total of $127K across 1 funding round:
Debt
$127K
Debt (2021): $127K with participation from PPP
Key Investors in Princeton Separations
PPP
Public-Private Partnership
What's next for Princeton Separations?
With the recent influx of capital, Princeton Separations is poised to transition into a phase of aggressive product commercialization and market penetration. The strategic focus will likely center on scaling the manufacturing and distribution of the Electro-Sep product line, which represents the next generation of their separation technology. By leveraging this late-stage financing, the company aims to deepen its integration into high-throughput research facilities and clinical diagnostic settings. Future growth trajectories will likely involve expanding their intellectual property portfolio and strengthening partnerships with key academic and commercial research institutions to maintain their competitive edge in the evolving landscape of molecular separation.
See full Princeton Separations company page
